Evidence map›Paper›PMID 31181056›Full record

ArticlePLoS medicine2019

Changes in rapid HIV treatment initiation after national "treat all" policy adoption in 6 sub-Saharan African countries: Regression discontinuity analysis.

Olga Tymejczyk, Ellen Brazier, Constantin T Yiannoutsos, Michael Vinikoor, Monique van Lettow, Fred Nalugoda, Mark Urassa, Jean d'Amour Sinayobye, Peter F Rebeiro, Kara Wools-Kaloustian and 7 more

Abstract read
In one paragraph

Article in PLoS medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Temporal trends in tuberculosis and time from enrolment in care to antiretroviral therapy initiation: A multicountry cohort study from Latin America.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2025
    Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Accelerating Well-being for Adolescents Through Transformative Public Policy: A Framework for Action.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Olga TymejczykInstitute for Implementation Science in Population Health, City University of New York, New York, New York, United States of America.ORCID 0000-0002-8417-0650
Ellen BrazierInstitute for Implementation Science in Population Health, City University of New York, New York, New York, United States of America.ORCID 0000-0002-8514-1958
Constantin T YiannoutsosRichard M. Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana, United States of America.ORCID 0000-0001-9014-3651
Michael VinikoorCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.ORCID 0000-0002-3862-7795
Monique van LettowDignitas International, Zomba, Malawi.
Fred NalugodaRakai Health Sciences Program, Kalisizo and Entebbe, Uganda.
Mark UrassaMwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania.ORCID 0000-0001-6756-9742
Jean d'Amour SinayobyeRwanda Military Hospital, Kigali, Rwanda.
Peter F RebeiroVanderbilt University School of Medicine, Nashville, Tennessee, United States of America.ORCID 0000-0003-1951-9104
Kara Wools-KaloustianDivision of Infectious Diseases, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
Mary-Ann DaviesCentre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.ORCID 0000-0001-8496-6475
Elizabeth ZaniewskiInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.ORCID 0000-0003-1986-2359
Nanina AndereggInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Grace LiuInstitute for Implementation Science in Population Health, City University of New York, New York, New York, United States of America.ORCID 0000-0003-4149-7386
Nathan FordGlobal Hepatitis Programme, HIV/AIDS Department, World Health Organization, Geneva, Switzerland.
Denis NashInstitute for Implementation Science in Population Health, City University of New York, New York, New York, United States of America.ORCID 0000-0002-3280-5386
IeDEA consortium

Funding

East Africa International Epidemiology Database to evaluate AIDS (IeDEA) Regional ConsortiumU01AI069911 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI AGGREY SEMWENDERO SEMEERE, Kara Kay Wools-Kaloustian · 2006 to 2026
$57.7M
Observational Antiretroviral Studies In Southern Africa (OASIS) CollaborationU01AI069924 · NIAID · UNIVERSITAT BERN · PI Cleophas Chimbetete, Mary-Ann Davies · 2006 to 2026
$55.9M
CCASAnet: Caribbean, Central and South America NetworkU01AI069923 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Pedro Enrique Cahn, Jessica L Castilho · 2006 to 2026
$41.6M
"Enhancing Cancer Research in Central Africa IeDEA"U01AI096299 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI Denis Nash, Marcel Yotebieng · 2011 to 2026
$35.8M
The HIV Care Continuum and Health Policy: Changes through Context and GeographyK01AI131895 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI REBEIRO, PETER F · 2017 to 2021
$623k
NIAID NIH HHS K01 AI131895NIAID NIH HHS U01 AI069911NIAID NIH HHS U01 AI069923NIAID NIH HHS U01 AI069924NIAID NIH HHS U01 AI096299World Health Organization 001
6 · The paper itself

Abstract

backgroundMost countries have formally adopted the World Health Organization's 2015 recommendation of universal HIV treatment ("treat all"). However, there are few rigorous assessments of the real-world impact of treat all policies on antiretroviral treatment (ART) uptake across different contexts. METHODS AND

findingsWe used longitudinal data for 814,603 patients enrolling in HIV care between 1 January 2004 and 10 July 2018 in 6 countries participating in the global International epidemiology Databases to Evaluate AIDS (IeDEA) consortium: Burundi (N = 11,176), Kenya (N = 179,941), Malawi (N = 84,558), Rwanda (N = 17,396), Uganda (N = 96,286), and Zambia (N = 425,246). Using a quasi-experimental regression discontinuity design, we assessed the change in the proportion initiating ART within 30 days of enrollment in HIV care (rapid ART initiation) after country-level adoption of the treat all policy. A modified Poisson model was used to identify factors associated with failure to initiate ART rapidly under treat all. In each of the 6 countries, over 60% of included patients were female, and median age at enrollment ranged from 32 to 36 years. In all countries studied, national adoption of treat all was associated with large increases in rapid ART initiation. Significant increases in rapid ART initiation immediately after treat all policy adoption were observed in Rwanda, from 44.4% to 78.9% of patients (34.5 percentage points [pp], 95% CI 27.2 to 41.7; p < 0.001), Kenya (25.7 pp, 95% CI 21.8 to 29.5; p < 0.001), Burundi (17.7 pp, 95% CI 6.5 to 28.9; p = 0.002), and Malawi (12.5 pp, 95% CI 7.5 to 17.5; p < 0.001), while no immediate increase was observed in Zambia (0.4 pp, 95% CI -2.9 to 3.8; p = 0.804) and Uganda (-4.2 pp, 95% CI -9.0 to 0.7; p = 0.090). The rate of rapid ART initiation accelerated sharply following treat all policy adoption in Malawi, Uganda, and Zambia; slowed in Kenya; and did not change in Rwanda and Burundi. In post hoc analyses restricted to patients enrolling under treat all, young adults (16-24 years) and men were at increased risk of not rapidly initiating ART (compared to older patients and women, respectively). However, rapid ART initiation following enrollment increased for all groups as more time elapsed since treat all policy adoption. Study limitations include incomplete data on potential ART eligibility criteria, such as clinical status, pregnancy, and enrollment CD4 count, which precluded the assessment of rapid ART initiation specifically among patients known to be eligible for ART before treat all.

conclusionsOur analysis indicates that adoption of treat all policies had a strong effect on increasing rates of rapid ART initiation, and that these increases followed different trajectories across the 6 countries. Young adults and men still require additional attention to further improve rapid ART initiation.

Indexed as

AdultAfrica South of the SaharaAnti-HIV AgentsFemaleHealth PolicyHIV InfectionsHumansLongitudinal StudiesMaleMiddle AgedRegression AnalysisTime FactorsAnti-HIV Agents

Identifiers

PMID31181056
PMCPMC6557472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.